| Share

MRI PRO & BXTACCELYON ON A MISSION TO COMBAT INACCURATE DIAGNOSIS OF PROSTATE CANCER



MRI Pro Pty. Ltd signs global distribution agreement with BXTAccelyon for the distribution of its flagship Prostate MRI e-learning platform.

With high-level evidence[1] now confirming prostate MRI’s place in the diagnostic process of prostate cancer detection, as well as adoption of the methodology in NICE[2], EAU[3], AUA[4] and national and international urology and radiology guidelines, demand for healthcare professionals experienced in interpreting and accurate reporting of MRI scans is skyrocketing. Gaining the experience that is required for accurate interpretation of prostate MRI is essential, l but is difficult to obtain without the availability of immediate histological feedback. MRI PRO addresses this global, unmet need.

 

MRI PRO is a subscription-based e-learning platform that allows healthcare professionals to test themselves on 300 of the highest quality histology-verified prostate MRI cases. All cases on MRI PRO are acquired and reported to PIRADS v.2 specifications, including access to histology reports.  Users submit their answers on PIRADS score, location of index lesions and staging information for each case, and get instant feedback on how they did, including access to the actual biopsy report. MRI PRO is uniquely positioned to have a significant impact on the way that doctors diagnose the disease and manage the treatment of men.

 

MRI PRO is also accredited by the European Accreditation Council for Continuing Medical Education (EACCME), the American Medical Association (AMA), the Royal Australasian College of Surgeons, and the Royal Australian and New Zealand College of Radiologists to earn CME points.

 

MRI PRO Co-Founder & Chairman, Assoc Prof Jeremy Grummet MBBS, MS, FRACS, said: “As an organisation, we are committed to improve the safety, precision, and efficiency of prostate cancer biopsy, and recognise the hugely important role MRI diagnostics can play. However, ensuring all healthcare professionals can gain the necessary experience to maximise the value of this methodology within the prostate cancer pathway, is key. These are values which are also closely mirrored by the team at BXTAccelyon; their approach to training whole prostate cancer teams in the PrecisionPoint biopsy device is one we welcome, and are keen to mirror. We are pleased to partner with BXTAccelyon with the aim of improving the overall patient experience and delivering the best possible health outcomes.”

 

Saheed Rashid, Managing Director, BXTAccelyon, adds: “Earlier and better detection of prostate cancer is proven to widen the available treatment options to patients, which will improve outcomes whilst reducing potential adverse side-effects and / or relapse. In recent years, we have made great strides in transforming traditional biopsy techniques, however, it is still the case that we currently diagnose cancers that are harmless, leading to unnecessary investigations and operations, and we miss cancers that are harmful. 

 

“Prostate MRI represents the next stage in prostate cancer diagnosis, but there is an unmet demand for education and training in MRI imaging and interpretation by urologist and radiologist. BXTAccelyon is therefore delighted to be the global distribution partner for this online learning platform that is paving the way for MRI education.”

Made in Australia for radiologists and urologists around the world, MRI PRO is the world's largest online trainer in prostate MRI. A team of the world's top experts from universities including Cambridge, Stanford, University of California San Francisco and New York University have advised on the program. 

For more information, or to see the tool in action, head to www.mripro.io

 

About MRI PRO PTY LTD: MRI PRO is a world’s industry standard online prostate MRI training tool designed to help doctors and health care professionals required to accurately diagnose prostate cancer scans from MRI machines and to learn how best to interpret these images. 

For media enquiries and/or high-resolution images please contact alext@mripro.io